| | Case Number | Title | Investigator |
| Select | 405 | Human FANCC Polyclonal Antibodies | A. D'Andrea |
| Select | 914 | Phospho-FANCD2 Monoclonal Antibodies | A. D'Andrea |
| Select | 234 | Methods to Clone PolyA mRNA (Differential Display) | A. Pardee |
| Select | 564 | HSIX1 Gene as a Diagnostic Marker for Breast Cancer | A. Pardee |
| Select | 574 | 2, 4-Diamino-6-(bridged diaryl) Aminomethylpteridines and Related Drugs Against Toxoplasmosis and Other Opportunistic Infections | A. Rosowsky |
| Select | 859 | Mode Rotation Operators in Radio Frequency Ion Traps | B. Reinhold |
| Select | 163 | aP2 Promoter and Adipocyte-Specific DNA Sequences and the Production of Transgenic Animals Exhibiting Altered Fat Tissue Metabolism | B. Spiegelman |
| Select | 266 | Treatment of Insulin Resistance in Obesity Linked Type II Diabetes Using Antagonists to TNF-Alpha Function | B. Spiegelman |
| Select | 485 | Use of PPAR Agents in the Treatment of Tumors of Fat | B. Spiegelman |
| Select | 534 | PGC-1, a Novel Brown Fat PPAR Coactivator | B. Spiegelman |
| Select | 593 | HIB I B Cells | B. Spiegelman |
| Select | 697 | PGC-1 Isoforms | B. Spiegelman |
| Select | 707 | PGC-1 and Gluconeogenesis. | B. Spiegelman |
| Select | 735 | aP2 Knock-Out Mice | B. Spiegelman |
| Select | 794 | PGC-1 Beta, a Novel Nuclear Receptor Coactive Related to PGC-1 | B. Spiegelman |
| Select | 795 | PPAR Gamma Null Fibroblasts-Cell Line | B. Spiegelman |
| Select | 811 | Induction of Slow-Twitch Muscle Fiber Program by PGC-1 | B. Spiegelman |
| Select | 780 | Receptor Linked Protein Tyrosine Phosphotases | C. Frederick |
| Select | 334 | Signal Transduction via CD28 | C. Rudd |
| Select | 241 | Activation-State-Specific Phosphoprotein Immunodetection | C. Stiles |
| Select | 558 | Melanoma Diagnostic | D. Fisher |
| Select | 350 | Methods of Inhibiting Undesirable Cell Growth Using a Combination of a Creatine Compound and a Hyperplastic Inhibitory Agent | D. Kufe |
| Select | 648 | Induction of Apoptosis By Reactive Oxygen Species | D. Kufe |
| Select | 792 | Treatment of Oxidative Damage | D. Kufe |
| Select | 825 | B6, 129s4 Ep300 (tm1Dli) Transgenic Mouse | D. Livingston |
|